Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-B4 (PCDHGB4) is a neural cadherin-like cell adhesion protein belonging to the protocadherin gamma gene cluster, located on chromosome 5[1][3][4]. This gene encodes a transmembrane protein with six extracellular cadherin repeats, likely mediating calcium-dependent adhesion, primarily within the nervous system. PCDHGB4 is thought to be involved in the establishment and maintenance of specific cell-cell (especially neuronal) connections in the brain, as well as potentially in wound healing by virtue of its expression in fibroblasts. The gene shows alternative splicing, and structural diversity is believed to support the complexity of neuronal connectivity[1][3][4][5]. No known drugs target this molecule, and it is not classified as a therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-B4 (PCDHGB4).